Best for
Mobile
How to buy AcelRx Pharmaceuticals shares
Own AcelRx Pharmaceuticals shares in just a few minutes. Share price changes are updated daily.
AcelRx Pharmaceuticals, Inc (ACRX) is a leading drug manufacturers-specialty & generic business based in the US. AcelRx Pharmaceuticals is listed on the NASDAQ and employs 99 staff. All prices are listed in US Dollars.
How to buy shares in AcelRx Pharmaceuticals
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: ACRX in this case.
- Research AcelRx Pharmaceuticals shares. The platform should provide the latest information available.
- Buy your AcelRx Pharmaceuticals shares. It's that simple.
What's in this guide?
- Can I buy shares in AcelRx Pharmaceuticals?
- AcelRx Pharmaceuticals shares summary
- Compare share dealing platforms
- Is AcelRx Pharmaceuticals stock a buy or sell?
- Can I short AcelRx Pharmaceuticals shares?
- AcelRx Pharmaceuticals's financials
- How volatile are AcelRx Pharmaceuticals shares?
- Does AcelRx Pharmaceuticals pay a dividend?
- Other common questions
AcelRx Pharmaceuticals share price
Use our graph to track the performance of ACRX stocks over time.AcelRx Pharmaceuticals shares at a glance
Information last updated 2021-01-24.
| 52-week range | $0.7014 - $2.94 |
|---|---|
| 50-day moving average | $1.4936 |
| 200-day moving average | $1.4247 |
| Wall St. target price | $5.46 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.711 |
Invest in AcelRx Pharmaceuticals shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy AcelRx Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
AcelRx Pharmaceuticals financials
| Revenue TTM | $5.2 million |
|---|---|
| Gross profit TTM | $-9,178,000 |
| Return on assets TTM | -34.11% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Market capitalisation | $189.7 million |
TTM: trailing 12 months
How to short and sell AcelRx Pharmaceuticals shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "ACRX.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 7.8 million AcelRx Pharmaceuticals shares held short by investors – that's known as AcelRx Pharmaceuticals's "short interest". This figure is 0.6% up from 7.8 million last month.
There are a few different ways that this level of interest in shorting AcelRx Pharmaceuticals shares can be evaluated.
AcelRx Pharmaceuticals's "short interest ratio" (SIR)
AcelRx Pharmaceuticals's "short interest ratio" (SIR) is the quantity of AcelRx Pharmaceuticals shares currently shorted divided by the average quantity of AcelRx Pharmaceuticals shares traded daily (recently around 1.5 million). AcelRx Pharmaceuticals's SIR currently stands at 5.1. In other words for every 100,000 AcelRx Pharmaceuticals shares traded daily on the market, roughly 5100 shares are currently held short.
However AcelRx Pharmaceuticals's short interest can also be evaluated against the total number of AcelRx Pharmaceuticals shares, or, against the total number of tradable AcelRx Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AcelRx Pharmaceuticals's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 AcelRx Pharmaceuticals shares in existence, roughly 90 shares are currently held short) or 0.0873% of the tradable shares (for every 100,000 tradable AcelRx Pharmaceuticals shares, roughly 87 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against AcelRx Pharmaceuticals.
Find out more about how you can short AcelRx Pharmaceuticals stock.
AcelRx Pharmaceuticals share dividends
We're not expecting AcelRx Pharmaceuticals to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
AcelRx Pharmaceuticals share price volatility
Over the last 12 months, AcelRx Pharmaceuticals's shares have ranged in value from as little as $0.7014 up to $2.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AcelRx Pharmaceuticals's is 1.1612. This would suggest that AcelRx Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
AcelRx Pharmaceuticals overview
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company's lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx Pharmaceuticals, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.
Frequently asked questions
More guides on Finder
-
How to buy AcelRx Pharmaceuticals shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy AcelRx Pharmaceuticals shares
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert